500% ist nix für diese Perle - 500 Beiträge pro Seite
eröffnet am 13.02.06 12:08:18 von
neuester Beitrag 30.11.06 23:56:28 von
neuester Beitrag 30.11.06 23:56:28 von
Beiträge: 40
ID: 1.039.874
ID: 1.039.874
Aufrufe heute: 0
Gesamt: 3.899
Gesamt: 3.899
Aktive User: 0
Top-Diskussionen
| Titel | letzter Beitrag | Aufrufe |
|---|---|---|
| vor 1 Stunde | 3103 | |
| heute 17:47 | 2253 | |
| heute 13:08 | 1646 | |
| heute 19:36 | 1580 | |
| heute 20:33 | 1474 | |
| vor 56 Minuten | 1356 | |
| heute 21:43 | 1345 | |
| heute 19:41 | 1304 |
Meistdiskutierte Wertpapiere
| Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
|---|---|---|---|---|---|---|---|
| 1. | 1. | 18.497,94 | +0,01 | 177 | |||
| 2. | 2. | 178,08 | -0,40 | 71 | |||
| 3. | 14. | 5,5260 | -1,11 | 48 | |||
| 4. | 6. | 4,1500 | +0,24 | 43 | |||
| 5. | 9. | 0,6906 | +12,73 | 38 | |||
| 6. | 4. | 0,1925 | 0,00 | 32 | |||
| 7. | 30. | 0,3340 | +76,72 | 31 | |||
| 8. | 39. | 6,4260 | +1,39 | 30 |
Feedback
Hi,
schaut euch mal Lifestream an ISIN:US53219K1016
Der wert stand 2002 bei 3,30€, jetzt ist er für läppische 0,01€ zu haben.
Ich denke mal die Chancen könnt ihr euch selber ausrechnen
.
Restrukturierung zeigt fortschritte und es wird nicht mehr lange dauern bis die erste empfehlung kommt und dann geht´s ab.
Aber schaut selbst
www.lifestreamtech.com
Habe mir schon einige 100k ins depot gelegt, jetzt abwarten und Tee trinken.
Bald machts BOOM....
Bis Dann
schaut euch mal Lifestream an ISIN:US53219K1016
Der wert stand 2002 bei 3,30€, jetzt ist er für läppische 0,01€ zu haben.
Ich denke mal die Chancen könnt ihr euch selber ausrechnen
.Restrukturierung zeigt fortschritte und es wird nicht mehr lange dauern bis die erste empfehlung kommt und dann geht´s ab.
Aber schaut selbst
www.lifestreamtech.com
Habe mir schon einige 100k ins depot gelegt, jetzt abwarten und Tee trinken.
Bald machts BOOM....
Bis Dann
wer oder was sagt Dir das die Aktie Qualität hat
vielleicht geht die auch auf 0,001
vielleicht geht die auch auf 0,001
Market Pulse Breaking News Alert for Tuesday, December 13, 2005: LFTC -- Lifestream Technologies Signs Agreement With Polymer for New Cholesterol/HDL Test!
Market Pulse News Alert for this AM, Stocks to Watch are: Lifestream Technologies, Inc. (OTC BB: LFTC), Myogen Inc. (NASDAQ: MYOG), 8x8 Inc. (NASDAQ: EGHT), and Insmed Inc. (NASDAQ: INSM).
Investors need to be watching Lifestream Technologies, Inc. (OTC BB: LFTC) this AM! Lifestream develops, markets and sells a line of smart card-enabled healthcare diagnostic devices. Lifestream has developed and currently markets a line of cholesterol monitors that provide test results in three minutes for at-home use by health conscious consumers and at-risk medical patients. Lifestream just had excellent news out in a press release before today`s opening bell announcing that it has entered into an agreement with Polymer Technology Systems, Inc., for supply of test strips for its new Cholesterol/HDL monitor! This could be great news for investors!
Lifestream Technologies, Inc. (OTC BB: LFTC), a leading supplier of cholesterol monitors, announced today that it has entered into an agreement with Polymer Technology Systems, Inc., for supply of test strips for its new Cholesterol/HDL monitor.
"We are pleased that Lifestream and Polymer will collaborate to bring consumers the ability to measure not only total cholesterol but also HDL cholesterol," said Christopher Maus, Lifestream`s CEO. "Now, those who know both their total and HDL cholesterol can determine if they have a ratio that increases or decreases their risk for coronary heart disease. The addition of this important test will complement our present product and expand our market opportunities."
The supply relationship with Polymer meets the stringent quality standards required by Lifestream and provides the Company with a very competitive price. Requested by consumers and pharmacists alike, the HDL cholesterol test will give consumers an additional tool in monitoring their risk for heart disease. The Cholesterol:HDL ratio is a better indicator of the number one cause of death, heart disease, than cholesterol alone. Consumer awareness for cholesterol testing and heart disease can be significantly increased with the addition of this new chemistry.
"Polymer is pleased to be partnering with Lifestream on this project," stated Robert S. Huffstodt, Polymer`s CEO. "This agreement is beneficial for both companies, and expands the choices for the health conscious consumer. The ability to perform both tests with one analyzer is more cost effective for the consumer and allows them to monitor two risk factors important in preventing or managing heart disease."
About Polymer Technology Systems, Inc.
Polymer Technology Systems, Inc. (PTS), is a privately held, medical device company that has developed a family of proprietary products to rapidly and accurately test cholesterol and other lipids in the blood. Millions worldwide are at risk for cardiovascular disease -- the leading cause of death in the U.S. today -- and may not know it. Increasing awareness by regularly monitoring their levels may reinforce lifestyle changes and/or drug treatments designed to reduce their level of risk.
PTS` unique technology has led to the first and only FDA-cleared and CLIA-waived blood testing analyzer suitable for both the professional point of care testing market and the home testing market. The PTS system consists of the CardioChek(TM) family of instruments, and PTS PANELS(TM) Test Strips, which can test total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, as well as other analytes.
About Lifestream Technologies
The Company developed and currently markets a cholesterol monitor to consumers and healthcare professionals that provides total cholesterol test results in three minutes.
The Company`s product aids the health conscious consumer in monitoring their risk of heart disease. By regularly testing cholesterol at home, individuals can monitor the benefits of their diet, exercise and/or drug therapy programs. Monitoring these benefits can support the physician and the individual`s efforts to improve compliance. Lifestream`s products also integrate a smart card reader further supporting compliance by storing test results on an individual`s personal health card for future retrieval, trend analysis and assessment.
Lifestream`s monitors are affordable, hand-held devices that provide users with accurate results in less than three minutes. The product line has been designed to accommodate The Data Concern(TM) Personal Health Card® allowing multiple users the ability to store their personal results. Lifestream`s products are now available in pharmacy and retail outlets nationwide. To find retailers that carry Lifestream`s products, go to "Store Locator" on www.knowitforlife.com or contact Customer Care at 888-954-LIFE. For Company information, visit www.lifestreamtech.com.
Stocks in the news and acting well as of late include: Myogen Inc. (NASDAQ: MYOG), 8x8 Inc. (NASDAQ: EGHT), and Insmed Inc. (NASDAQ: INSM).
Information contained herein is the opinion of Market-Pulse.com ("MP") and is intended to be used strictly for informational purposes. You should be aware that MP attempts to assure itself of the accuracy of the information contained in the analyses it publishes. In this regard, MP does, at times, rely on the accuracy of information supplied to it by the companies which are the subject of MP`s analyses and/or parties related to those companies. MP also relies on the accuracy and integrity of information that is contained in company press releases and reports filed with the SEC. The companies mentioned in this publication have not approved the content or timing of the information being published unless otherwise noted.
MP, because it relies on information supplied by various third parties disclaims any responsibility for the accuracy of such information. Any investor considering making an investment in any security which has been the subject of a MP analysis or opinion should, before making any such investment, consult with his/her market professional and/or do his/her own independent research regarding the company which is the subject of an MP opinion, recommendation or analysis. Information regarding companies which MP has opined upon is normally available from many sources including the subject company`s filings with the SEC and various press releases issued by the company.
You should be aware that MP is often compensated for issuing analyses, recommendations or opinions concerning particular companies. Its opinion is therefore not unbiased and you should consider this factor when evaluating MP`s statements regarding a company. MP was compensated by a third party shareholder with three million free trading shares of common stock of Lifestream Technologies, Inc. ("Lifestream"). MP was also compensated an additional three million restricted shares of common stock directly from Lifestream. The restricted shares that MP received directly from Lifestream were subsequently registered by Lifestream with the Securities and Exchange Commission and may now be resold by MP without restriction. To date, MP has sold three million shares of stock in Lifestream for proceeds totaling ninety five thousand and three hundred dollars. MP`s officers and directors reserve the right to buy additional shares of the companies discussed in this opinion and may profit in the event those shares rise in value. When MP receives free trading shares as compensation for a profiled company, MP may sell part or all of any such shares during the period in which MP is performing such services. Market-Pulse.com and Market Pulse Breaking News Alert are owned by Market Pulse LLC.
Source: Market Wire (December 13, 2005 - 8:30 AM EST)
News by QuoteMedia
Market Pulse News Alert for this AM, Stocks to Watch are: Lifestream Technologies, Inc. (OTC BB: LFTC), Myogen Inc. (NASDAQ: MYOG), 8x8 Inc. (NASDAQ: EGHT), and Insmed Inc. (NASDAQ: INSM).
Investors need to be watching Lifestream Technologies, Inc. (OTC BB: LFTC) this AM! Lifestream develops, markets and sells a line of smart card-enabled healthcare diagnostic devices. Lifestream has developed and currently markets a line of cholesterol monitors that provide test results in three minutes for at-home use by health conscious consumers and at-risk medical patients. Lifestream just had excellent news out in a press release before today`s opening bell announcing that it has entered into an agreement with Polymer Technology Systems, Inc., for supply of test strips for its new Cholesterol/HDL monitor! This could be great news for investors!
Lifestream Technologies, Inc. (OTC BB: LFTC), a leading supplier of cholesterol monitors, announced today that it has entered into an agreement with Polymer Technology Systems, Inc., for supply of test strips for its new Cholesterol/HDL monitor.
"We are pleased that Lifestream and Polymer will collaborate to bring consumers the ability to measure not only total cholesterol but also HDL cholesterol," said Christopher Maus, Lifestream`s CEO. "Now, those who know both their total and HDL cholesterol can determine if they have a ratio that increases or decreases their risk for coronary heart disease. The addition of this important test will complement our present product and expand our market opportunities."
The supply relationship with Polymer meets the stringent quality standards required by Lifestream and provides the Company with a very competitive price. Requested by consumers and pharmacists alike, the HDL cholesterol test will give consumers an additional tool in monitoring their risk for heart disease. The Cholesterol:HDL ratio is a better indicator of the number one cause of death, heart disease, than cholesterol alone. Consumer awareness for cholesterol testing and heart disease can be significantly increased with the addition of this new chemistry.
"Polymer is pleased to be partnering with Lifestream on this project," stated Robert S. Huffstodt, Polymer`s CEO. "This agreement is beneficial for both companies, and expands the choices for the health conscious consumer. The ability to perform both tests with one analyzer is more cost effective for the consumer and allows them to monitor two risk factors important in preventing or managing heart disease."
About Polymer Technology Systems, Inc.
Polymer Technology Systems, Inc. (PTS), is a privately held, medical device company that has developed a family of proprietary products to rapidly and accurately test cholesterol and other lipids in the blood. Millions worldwide are at risk for cardiovascular disease -- the leading cause of death in the U.S. today -- and may not know it. Increasing awareness by regularly monitoring their levels may reinforce lifestyle changes and/or drug treatments designed to reduce their level of risk.
PTS` unique technology has led to the first and only FDA-cleared and CLIA-waived blood testing analyzer suitable for both the professional point of care testing market and the home testing market. The PTS system consists of the CardioChek(TM) family of instruments, and PTS PANELS(TM) Test Strips, which can test total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, as well as other analytes.
About Lifestream Technologies
The Company developed and currently markets a cholesterol monitor to consumers and healthcare professionals that provides total cholesterol test results in three minutes.
The Company`s product aids the health conscious consumer in monitoring their risk of heart disease. By regularly testing cholesterol at home, individuals can monitor the benefits of their diet, exercise and/or drug therapy programs. Monitoring these benefits can support the physician and the individual`s efforts to improve compliance. Lifestream`s products also integrate a smart card reader further supporting compliance by storing test results on an individual`s personal health card for future retrieval, trend analysis and assessment.
Lifestream`s monitors are affordable, hand-held devices that provide users with accurate results in less than three minutes. The product line has been designed to accommodate The Data Concern(TM) Personal Health Card® allowing multiple users the ability to store their personal results. Lifestream`s products are now available in pharmacy and retail outlets nationwide. To find retailers that carry Lifestream`s products, go to "Store Locator" on www.knowitforlife.com or contact Customer Care at 888-954-LIFE. For Company information, visit www.lifestreamtech.com.
Stocks in the news and acting well as of late include: Myogen Inc. (NASDAQ: MYOG), 8x8 Inc. (NASDAQ: EGHT), and Insmed Inc. (NASDAQ: INSM).
Information contained herein is the opinion of Market-Pulse.com ("MP") and is intended to be used strictly for informational purposes. You should be aware that MP attempts to assure itself of the accuracy of the information contained in the analyses it publishes. In this regard, MP does, at times, rely on the accuracy of information supplied to it by the companies which are the subject of MP`s analyses and/or parties related to those companies. MP also relies on the accuracy and integrity of information that is contained in company press releases and reports filed with the SEC. The companies mentioned in this publication have not approved the content or timing of the information being published unless otherwise noted.
MP, because it relies on information supplied by various third parties disclaims any responsibility for the accuracy of such information. Any investor considering making an investment in any security which has been the subject of a MP analysis or opinion should, before making any such investment, consult with his/her market professional and/or do his/her own independent research regarding the company which is the subject of an MP opinion, recommendation or analysis. Information regarding companies which MP has opined upon is normally available from many sources including the subject company`s filings with the SEC and various press releases issued by the company.
You should be aware that MP is often compensated for issuing analyses, recommendations or opinions concerning particular companies. Its opinion is therefore not unbiased and you should consider this factor when evaluating MP`s statements regarding a company. MP was compensated by a third party shareholder with three million free trading shares of common stock of Lifestream Technologies, Inc. ("Lifestream"). MP was also compensated an additional three million restricted shares of common stock directly from Lifestream. The restricted shares that MP received directly from Lifestream were subsequently registered by Lifestream with the Securities and Exchange Commission and may now be resold by MP without restriction. To date, MP has sold three million shares of stock in Lifestream for proceeds totaling ninety five thousand and three hundred dollars. MP`s officers and directors reserve the right to buy additional shares of the companies discussed in this opinion and may profit in the event those shares rise in value. When MP receives free trading shares as compensation for a profiled company, MP may sell part or all of any such shares during the period in which MP is performing such services. Market-Pulse.com and Market Pulse Breaking News Alert are owned by Market Pulse LLC.
Source: Market Wire (December 13, 2005 - 8:30 AM EST)
News by QuoteMedia
Market Pulse Breaking News Alert for Thursday, December 1, 2005: LFTC -- Lifestream Technologies Signs Agreement With GenExel for New Three-in-One Unit!
Market Pulse News Alert for this AM, Stocks to Watch are: Lifestream Technologies, Inc. (OTC BB: LFTC), BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX), Google Inc. (NASDAQ: GOOG), and JDS Uniphase Corp. (NASDAQ: JDSU).
Investors need to be watching Lifestream Technologies, Inc. (OTC BB: LFTC) this AM! Lifestream develops, markets and sells a line of smart card-enabled healthcare diagnostic devices. Lifestream has developed and currently markets a line of cholesterol monitors that provide test results in three minutes for at-home use by health conscious consumers and at-risk medical patients. Lifestream just had excellent news out in a press release before today`s opening bell announcing that it has entered into an agreement with GenExel-Sein, Inc., for the production of the new Lifestream three-in-one blood pressure monitor! This could be great news for investors!
Lifestream Technologies, Inc. (OTC BB: LFTC), a leading supplier of cholesterol monitors, announced today that it has entered into an agreement with GenExel-Sein, Inc., for the production of the new Lifestream Three In One Blood Pressure monitor.
"We are pleased that, after over 6 months of review and discussions with numerous blood pressure manufacturers, GenExel met our stringent quality standards and had the clarity of vision for this market opportunity," stated Christopher Maus, Lifestream`s CEO. "This new technology will complement our product line and expand our present market opportunities in an area not yet commercialized."
The new Lifestream "Three-in-One" Blood Pressure monitor will measure blood pressure, cholesterol and HDL, all in less than three minutes. Consumer awareness for cholesterol testing can be significantly expanded through this merger. Between 5 to 7 million blood pressure monitors are sold each year in the U. S. or 14 million worldwide.
"The health conscious consumer, who uses or will use a blood pressure monitor, now has a real clear choice," continued Maus. "This dual use device supplies more meaningful information about a consumer`s cardiac health. The combined unit is also more cost effective and will play an essential role for individuals who are managing both blood pressure and cholesterol. There is an estimated 73% overlap of individuals with elevated blood pressure and high cholesterol. About 20 million people are on both blood pressure and cholesterol lowering medications."
"GenExel is pleased to be partnering with Lifestream on this very innovative product," said Dr. Douglas Stafford, Executive Vice President of GenExel. "Lifestream understands the market as much as GenExel does. This collaboration is perfect given that GenExel is also bringing an innovative Blood Pressure/Glucose monitor to the market. This product is a natural evolution for the hypertensive market. Together, Lifestream and GenExel have an opportunity to meet the goals of both companies and give health conscious consumers more quality choices."
About GenExel-Sein, Inc.
GenExel is a rapidly growing medical products company with headquarters in South Korea. Its business units provide innovative products for home medical diagnosis and engage in the discovery and development of pharmaceutical products with an emphasis on central system disorders (such as Alzheimer`s disease and Parkinson`s disease). The company has operating subsidiaries in South Korea, China, Germany, the United Kingdom, and the United States. It is traded publicly on the KOSDAQ under the symbol GENEXEL. For more information, visit GenExel-Sein online at www.seinbpm.com or www.genexel.com. Contact: GenExel-Sein, Inc., 111 Seocho-Gu, YangJae-1 Dong, Namkyung Bldg 3rd Floor 137-891, Seoul, South Korea, for more information on the company.
About Lifestream Technologies
The Company developed and currently markets a cholesterol monitor to consumers and healthcare professionals that provide total cholesterol test results in three minutes. The Company`s product aids the health conscious consumer in monitoring their risk of heart disease. By regularly testing cholesterol at home, individuals can monitor the benefits of their diet, exercise and/or drug therapy programs. Monitoring these benefits can support the physician and the individual`s efforts to improve compliance. Lifestream`s products also integrate a smart card reader further supporting compliance by storing test results on an individual`s personal health card for future retrieval, trend analysis and assessment.
Lifestream`s monitors are affordable, hand-held devices that provide users with accurate results in less than three minutes. The product line has been designed to accommodate The Data Concern(TM) Personal Health Card® allowing multiple users the ability to store their personal results. Lifestream`s products are now available in pharmacy and retail outlets nationwide. To find retailers that carry Lifestream`s products, go to "Store Locator" on www.knowitforlife.com or contact Customer Care at 888-954-LIFE. For Company information, visit www.lifestreamtech.com.
Stocks in the news and acting well as of late include: BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX), Google Inc. (NASDAQ: GOOG), and JDS Uniphase Corp. (NASDAQ: JDSU).
Information contained herein is the opinion of Market-Pulse.com ("MP") and is intended to be used strictly for informational purposes. You should be aware that MP attempts to assure itself of the accuracy of the information contained in the analyses it publishes. In this regard, MP does, at times, rely on the accuracy of information supplied to it by the companies which are the subject of MP`s analyses and/or parties related to those companies. MP also relies on the accuracy and integrity of information that is contained in company press releases and reports filed with the SEC. The companies mentioned in this publication have not approved the content or timing of the information being published unless otherwise noted.
MP, because it relies on information supplied by various third parties disclaims any responsibility for the accuracy of such information. Any investor considering making an investment in any security which has been the subject of a MP analysis or opinion should, before making any such investment, consult with his/her market professional and/or do his/her own independent research regarding the company which is the subject of an MP opinion, recommendation or analysis. Information regarding companies which MP has opined upon is normally available from many sources including the subject company`s filings with the SEC and various press releases issued by the company.
You should be aware that MP is often compensated for issuing analyses, recommendations or opinions concerning particular companies. Its opinion is therefore not unbiased and you should consider this factor when evaluating MP`s statements regarding a company. MP was compensated by a third party shareholder with three million free trading shares of common stock of Lifestream Technologies, Inc. ("Lifestream"). MP was also compensated an additional three million restricted shares of common stock directly from Lifestream. The restricted shares that MP received directly from Lifestream were subsequently registered by Lifestream with the Securities and Exchange Commission and may now be resold by MP without restriction. To date, MP has sold three million shares of stock in Lifestream for proceeds totaling ninety five thousand and three hundred dollars. MP`s officers and directors reserve the right to buy additional shares of the companies discussed in this opinion and may profit in the event those shares rise in value. When MP receives free trading shares as compensation for a profiled company, MP may sell part or all of any such shares during the period in which MP is performing such services. Market-Pulse.com and Market Pulse Breaking News Alert are owned by Market Pulse LLC.
Source: Market Wire (December 1, 2005 - 8:30 AM EST)
News by QuoteMedia
www.quotemedia.com
Market Pulse News Alert for this AM, Stocks to Watch are: Lifestream Technologies, Inc. (OTC BB: LFTC), BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX), Google Inc. (NASDAQ: GOOG), and JDS Uniphase Corp. (NASDAQ: JDSU).
Investors need to be watching Lifestream Technologies, Inc. (OTC BB: LFTC) this AM! Lifestream develops, markets and sells a line of smart card-enabled healthcare diagnostic devices. Lifestream has developed and currently markets a line of cholesterol monitors that provide test results in three minutes for at-home use by health conscious consumers and at-risk medical patients. Lifestream just had excellent news out in a press release before today`s opening bell announcing that it has entered into an agreement with GenExel-Sein, Inc., for the production of the new Lifestream three-in-one blood pressure monitor! This could be great news for investors!
Lifestream Technologies, Inc. (OTC BB: LFTC), a leading supplier of cholesterol monitors, announced today that it has entered into an agreement with GenExel-Sein, Inc., for the production of the new Lifestream Three In One Blood Pressure monitor.
"We are pleased that, after over 6 months of review and discussions with numerous blood pressure manufacturers, GenExel met our stringent quality standards and had the clarity of vision for this market opportunity," stated Christopher Maus, Lifestream`s CEO. "This new technology will complement our product line and expand our present market opportunities in an area not yet commercialized."
The new Lifestream "Three-in-One" Blood Pressure monitor will measure blood pressure, cholesterol and HDL, all in less than three minutes. Consumer awareness for cholesterol testing can be significantly expanded through this merger. Between 5 to 7 million blood pressure monitors are sold each year in the U. S. or 14 million worldwide.
"The health conscious consumer, who uses or will use a blood pressure monitor, now has a real clear choice," continued Maus. "This dual use device supplies more meaningful information about a consumer`s cardiac health. The combined unit is also more cost effective and will play an essential role for individuals who are managing both blood pressure and cholesterol. There is an estimated 73% overlap of individuals with elevated blood pressure and high cholesterol. About 20 million people are on both blood pressure and cholesterol lowering medications."
"GenExel is pleased to be partnering with Lifestream on this very innovative product," said Dr. Douglas Stafford, Executive Vice President of GenExel. "Lifestream understands the market as much as GenExel does. This collaboration is perfect given that GenExel is also bringing an innovative Blood Pressure/Glucose monitor to the market. This product is a natural evolution for the hypertensive market. Together, Lifestream and GenExel have an opportunity to meet the goals of both companies and give health conscious consumers more quality choices."
About GenExel-Sein, Inc.
GenExel is a rapidly growing medical products company with headquarters in South Korea. Its business units provide innovative products for home medical diagnosis and engage in the discovery and development of pharmaceutical products with an emphasis on central system disorders (such as Alzheimer`s disease and Parkinson`s disease). The company has operating subsidiaries in South Korea, China, Germany, the United Kingdom, and the United States. It is traded publicly on the KOSDAQ under the symbol GENEXEL. For more information, visit GenExel-Sein online at www.seinbpm.com or www.genexel.com. Contact: GenExel-Sein, Inc., 111 Seocho-Gu, YangJae-1 Dong, Namkyung Bldg 3rd Floor 137-891, Seoul, South Korea, for more information on the company.
About Lifestream Technologies
The Company developed and currently markets a cholesterol monitor to consumers and healthcare professionals that provide total cholesterol test results in three minutes. The Company`s product aids the health conscious consumer in monitoring their risk of heart disease. By regularly testing cholesterol at home, individuals can monitor the benefits of their diet, exercise and/or drug therapy programs. Monitoring these benefits can support the physician and the individual`s efforts to improve compliance. Lifestream`s products also integrate a smart card reader further supporting compliance by storing test results on an individual`s personal health card for future retrieval, trend analysis and assessment.
Lifestream`s monitors are affordable, hand-held devices that provide users with accurate results in less than three minutes. The product line has been designed to accommodate The Data Concern(TM) Personal Health Card® allowing multiple users the ability to store their personal results. Lifestream`s products are now available in pharmacy and retail outlets nationwide. To find retailers that carry Lifestream`s products, go to "Store Locator" on www.knowitforlife.com or contact Customer Care at 888-954-LIFE. For Company information, visit www.lifestreamtech.com.
Stocks in the news and acting well as of late include: BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX), Google Inc. (NASDAQ: GOOG), and JDS Uniphase Corp. (NASDAQ: JDSU).
Information contained herein is the opinion of Market-Pulse.com ("MP") and is intended to be used strictly for informational purposes. You should be aware that MP attempts to assure itself of the accuracy of the information contained in the analyses it publishes. In this regard, MP does, at times, rely on the accuracy of information supplied to it by the companies which are the subject of MP`s analyses and/or parties related to those companies. MP also relies on the accuracy and integrity of information that is contained in company press releases and reports filed with the SEC. The companies mentioned in this publication have not approved the content or timing of the information being published unless otherwise noted.
MP, because it relies on information supplied by various third parties disclaims any responsibility for the accuracy of such information. Any investor considering making an investment in any security which has been the subject of a MP analysis or opinion should, before making any such investment, consult with his/her market professional and/or do his/her own independent research regarding the company which is the subject of an MP opinion, recommendation or analysis. Information regarding companies which MP has opined upon is normally available from many sources including the subject company`s filings with the SEC and various press releases issued by the company.
You should be aware that MP is often compensated for issuing analyses, recommendations or opinions concerning particular companies. Its opinion is therefore not unbiased and you should consider this factor when evaluating MP`s statements regarding a company. MP was compensated by a third party shareholder with three million free trading shares of common stock of Lifestream Technologies, Inc. ("Lifestream"). MP was also compensated an additional three million restricted shares of common stock directly from Lifestream. The restricted shares that MP received directly from Lifestream were subsequently registered by Lifestream with the Securities and Exchange Commission and may now be resold by MP without restriction. To date, MP has sold three million shares of stock in Lifestream for proceeds totaling ninety five thousand and three hundred dollars. MP`s officers and directors reserve the right to buy additional shares of the companies discussed in this opinion and may profit in the event those shares rise in value. When MP receives free trading shares as compensation for a profiled company, MP may sell part or all of any such shares during the period in which MP is performing such services. Market-Pulse.com and Market Pulse Breaking News Alert are owned by Market Pulse LLC.
Source: Market Wire (December 1, 2005 - 8:30 AM EST)
News by QuoteMedia
www.quotemedia.com
Market Pulse Breaking News Alert for Friday, Oct. 14, 2005: LFTC - Lifestream Technologies Signs License Agreements With LifeNexus!
Market Pulse News Alert for this AM, Stocks to Watch are: Lifestream Technologies, Inc. (OTC BB: LFTC), Apple Computer Inc. (NASDAQ: AAPL), General Electric Co. (NYSE: GE), and US Energy Systems Inc. (NASDAQ: USEY).
Investors need to be watching Lifestream Technologies, Inc. (OTC BB: LFTC) this AM! Lifestream develops, markets and sells a line of smart card-enabled healthcare diagnostic devices. Lifestream has developed and currently markets a line of cholesterol monitors that provide test results in three minutes for at-home use by health-conscious consumers and at-risk medical patients. Lifestream just had excellent news out before today`s opening bell announcing today that it has entered into non-exclusive license agreements with LifeNexus, Inc., to use Lifestream`s technology in exchange for future royalties! This could be great news for investors!
Lifestream Technologies, Inc. (OTC BB: LFTC), a leading supplier of cholesterol monitors, announced today that it has entered into non-exclusive license agreements with LifeNexus, Inc., to use Lifestream`s technology in exchange for future royalties.
"We are pleased to have this opportunity to receive value for this technology, which has no material value to the Company since our current resources are being focused on our core business," stated Christopher Maus, Lifestream`s CEO. "This technology has not been commercialized as market conditions were not conducive to support the costs related to an effective rollout. With national attention focusing on revamping the healthcare information system, we believe this arrangement provides an opportunity for Lifestream and its shareholders. LifeNexus has developed an innovative approach to a portable medical record in concert with powerful healthcare financial services creating a viable opportunity for commercializing this technology. We look forward to profiting from its success."
"This arrangement brings considerable value to consumers as the LifeNexus personal health card is a universal solution for the portability of medical records," said Maus. "We wish LifeNexus the best in their endeavors and look forward to future income through royalty payments."
These agreements replace the previous Intellectual Property and Capital Purchase Agreement between the companies, which terminated August 1, 2005.
About Lifestream Technologies
The Company developed and currently markets a cholesterol monitor to consumers and healthcare professionals that provides test results in three minutes.
The Company`s products aid the health-conscious consumer in monitoring their risk of heart disease. By regularly testing cholesterol at home, individuals can monitor the benefits of their diet, exercise and/or drug therapy programs. Monitoring these benefits can support the physician and the individual`s efforts to improve compliance. Lifestream`s monitor also integrates a smart card reader further supporting compliance by storing test results on an individual`s personal health card for future retrieval.
Lifestream`s monitor is an affordable, hand-held device designed to accommodate the Personal Health Card® allowing multiple users the ability to store their personal results. Lifestream products are now available in pharmacy and retail outlets nationwide. To find retailers that carry Lifestream`s products, go to "Store Locator" on www.knowitforlife.com or contact Customer Care at 888-954-LIFE. For Company information, visit www.lifestreamtech.com.
About LifeNexus, Inc.
LifeNexus, Inc., is a privately-held company focused on the development and marketing of personal health care on a smart card platform incorporating emergency medical information, emergency medical insurance, accidental life and other financial products.
Stocks in the news and acting well as of late include: Apple Computer Inc. (NASDAQ: AAPL), General Electric Co. (NYSE: GE), and US Energy Systems Inc. (NASDAQ: USEY).
Information contained herein is the opinion of Market-Pulse.com ("MP") and is intended to be used strictly for informational purposes. You should be aware that MP attempts to assure itself of the accuracy of the information contained in the analyses it publishes. In this regard, MP does, at times, rely on the accuracy of information supplied to it by the companies which are the subject of MP`s analyses and/or parties related to those companies. MP also relies on the accuracy and integrity of information that is contained in company press releases and reports filed with the SEC. The companies mentioned in this publication have not approved the content or timing of the information being published unless otherwise noted.
MP, because it relies on information supplied by various third parties disclaims any responsibility for the accuracy of such information. Any investor considering making an investment in any security which has been the subject of a MP analysis or opinion should, before making any such investment, consult with his/her market professional and/or do his/her own independent research regarding the company which is the subject of an MP opinion, recommendation or analysis. Information regarding companies which MP has opined upon is normally available from many sources including the subject company`s filings with the SEC and various press releases issued by the company.
You should be aware that MP is often compensated for issuing analyses, recommendations or opinions concerning particular companies. Its opinion is therefore not unbiased and you should consider this factor when evaluating MP`s statements regarding a company. MP was compensated by a third party shareholder with three million free trading shares of common stock of Lifestream Technologies, Inc. ("Lifestream"). MP was also compensated an additional three million restricted shares of common stock directly from Lifestream. The restricted shares that MP received directly from Lifestream were subsequently registered by Lifestream with the Securities and Exchange Commission and may now be resold by MP without restriction. To date, MP has sold three million shares of stock in Lifestream for proceeds totaling ninety five thousand and three hundred dollars. MP`s officers and directors reserve the right to buy additional shares of the companies discussed in this opinion and may profit in the event those shares rise in value. When MP receives free trading shares as compensation for a profiled company, MP may sell part or all of any such shares during the period in which MP is performing such services. Market-Pulse.com and Market Pulse Breaking News Alert are owned by Market Pulse LLC.
Source: Market Wire (October 14, 2005 - 11:30 AM EDT)
News by QuoteMedia
www.quotemedia.com
Market Pulse News Alert for this AM, Stocks to Watch are: Lifestream Technologies, Inc. (OTC BB: LFTC), Apple Computer Inc. (NASDAQ: AAPL), General Electric Co. (NYSE: GE), and US Energy Systems Inc. (NASDAQ: USEY).
Investors need to be watching Lifestream Technologies, Inc. (OTC BB: LFTC) this AM! Lifestream develops, markets and sells a line of smart card-enabled healthcare diagnostic devices. Lifestream has developed and currently markets a line of cholesterol monitors that provide test results in three minutes for at-home use by health-conscious consumers and at-risk medical patients. Lifestream just had excellent news out before today`s opening bell announcing today that it has entered into non-exclusive license agreements with LifeNexus, Inc., to use Lifestream`s technology in exchange for future royalties! This could be great news for investors!
Lifestream Technologies, Inc. (OTC BB: LFTC), a leading supplier of cholesterol monitors, announced today that it has entered into non-exclusive license agreements with LifeNexus, Inc., to use Lifestream`s technology in exchange for future royalties.
"We are pleased to have this opportunity to receive value for this technology, which has no material value to the Company since our current resources are being focused on our core business," stated Christopher Maus, Lifestream`s CEO. "This technology has not been commercialized as market conditions were not conducive to support the costs related to an effective rollout. With national attention focusing on revamping the healthcare information system, we believe this arrangement provides an opportunity for Lifestream and its shareholders. LifeNexus has developed an innovative approach to a portable medical record in concert with powerful healthcare financial services creating a viable opportunity for commercializing this technology. We look forward to profiting from its success."
"This arrangement brings considerable value to consumers as the LifeNexus personal health card is a universal solution for the portability of medical records," said Maus. "We wish LifeNexus the best in their endeavors and look forward to future income through royalty payments."
These agreements replace the previous Intellectual Property and Capital Purchase Agreement between the companies, which terminated August 1, 2005.
About Lifestream Technologies
The Company developed and currently markets a cholesterol monitor to consumers and healthcare professionals that provides test results in three minutes.
The Company`s products aid the health-conscious consumer in monitoring their risk of heart disease. By regularly testing cholesterol at home, individuals can monitor the benefits of their diet, exercise and/or drug therapy programs. Monitoring these benefits can support the physician and the individual`s efforts to improve compliance. Lifestream`s monitor also integrates a smart card reader further supporting compliance by storing test results on an individual`s personal health card for future retrieval.
Lifestream`s monitor is an affordable, hand-held device designed to accommodate the Personal Health Card® allowing multiple users the ability to store their personal results. Lifestream products are now available in pharmacy and retail outlets nationwide. To find retailers that carry Lifestream`s products, go to "Store Locator" on www.knowitforlife.com or contact Customer Care at 888-954-LIFE. For Company information, visit www.lifestreamtech.com.
About LifeNexus, Inc.
LifeNexus, Inc., is a privately-held company focused on the development and marketing of personal health care on a smart card platform incorporating emergency medical information, emergency medical insurance, accidental life and other financial products.
Stocks in the news and acting well as of late include: Apple Computer Inc. (NASDAQ: AAPL), General Electric Co. (NYSE: GE), and US Energy Systems Inc. (NASDAQ: USEY).
Information contained herein is the opinion of Market-Pulse.com ("MP") and is intended to be used strictly for informational purposes. You should be aware that MP attempts to assure itself of the accuracy of the information contained in the analyses it publishes. In this regard, MP does, at times, rely on the accuracy of information supplied to it by the companies which are the subject of MP`s analyses and/or parties related to those companies. MP also relies on the accuracy and integrity of information that is contained in company press releases and reports filed with the SEC. The companies mentioned in this publication have not approved the content or timing of the information being published unless otherwise noted.
MP, because it relies on information supplied by various third parties disclaims any responsibility for the accuracy of such information. Any investor considering making an investment in any security which has been the subject of a MP analysis or opinion should, before making any such investment, consult with his/her market professional and/or do his/her own independent research regarding the company which is the subject of an MP opinion, recommendation or analysis. Information regarding companies which MP has opined upon is normally available from many sources including the subject company`s filings with the SEC and various press releases issued by the company.
You should be aware that MP is often compensated for issuing analyses, recommendations or opinions concerning particular companies. Its opinion is therefore not unbiased and you should consider this factor when evaluating MP`s statements regarding a company. MP was compensated by a third party shareholder with three million free trading shares of common stock of Lifestream Technologies, Inc. ("Lifestream"). MP was also compensated an additional three million restricted shares of common stock directly from Lifestream. The restricted shares that MP received directly from Lifestream were subsequently registered by Lifestream with the Securities and Exchange Commission and may now be resold by MP without restriction. To date, MP has sold three million shares of stock in Lifestream for proceeds totaling ninety five thousand and three hundred dollars. MP`s officers and directors reserve the right to buy additional shares of the companies discussed in this opinion and may profit in the event those shares rise in value. When MP receives free trading shares as compensation for a profiled company, MP may sell part or all of any such shares during the period in which MP is performing such services. Market-Pulse.com and Market Pulse Breaking News Alert are owned by Market Pulse LLC.
Source: Market Wire (October 14, 2005 - 11:30 AM EDT)
News by QuoteMedia
www.quotemedia.com
Trading Spotlight
Und das alles ist noch nicht im Kurs enthalten
[posting]20.178.325 von Denis1982 am 13.02.06 12:47:03[/posting]Aber , dass die am 01. Februar 3,36 Mio. Dollar Schulden nicht bezahlen konnten, ist sicherlich eingepreist, oder ???
Man, die sind pleite !!!!!!!!
Man, die sind pleite !!!!!!!!
hoffe auch auf eine kursvervielfältigung.........aber lifestream eine perle zu nennen......ist nun wirklich der dümmste dummpush den es bei wo gibt
Lifestream Receives Notice of Allowance from the U. S. Patent and Trademark Office
Friday April 14, 6:30 am ET
Indicates That a Key Patent Will Be Granted
POST FALLS, Idaho--(BUSINESS WIRE)--April 14, 2006--Lifestream Technologies, Inc. (OTCBB:LFTC - News), a leading developer and marketer of consumer cholesterol monitors and professional screening instruments, has received a Notice of Allowance for a key patent from the U. S. Patent and Trademark office that further strengthens its Intellectual Property "IP" portfolio.
"Lifestream received a Notice of Allowance from the U. S. Patent and Trademark Office for its smartcard, secure medical data technology," stated patent counsel, Mike Mehrman. "This action indicates that the patent will be granted after the short period of time required to print the formal patent. This patent will cover Lifestream's Personal Health Card technology, including the unique method in which a person's medical data can be securely stored on a smartcard, as well as the secure storage of medical records on a backside server."
"With the subject of portable health records heating up, Lifestream sees this technology playing a key role in providing secure, portable medical records. The technology has already been licensed to one company, LifeNexus, Inc., and, as soon as the LifeNexus product enters the marketplace, Lifestream will be entitled to receive a royalty," said Matt Colbert, Lifestream's President and CFO.
"The Company's goal has been to secure its IP assets in such a way as to maximize their value to our shareholders through viable technologies. Our creative technical team continues to play a key role in our future success. As we move into the next generation of products, we will strive to be on the leading edge with the application of our technology in products of value to our customers and shareholders. Lifestream has a number of other applications related to our future product offerings," continued Mr. Colbert.
Ed Siemens has been appointed by the Board of Directors to the position of Chairman, and Matt Colbert has been appointed as President and Chief Financial Officer, replacing Christopher Maus, who will remain as a Director with the Company, as well as a consultant to facilitate financing and strategic business development.
About Lifestream Technologies, Inc.
The Company developed and currently markets a cholesterol monitor to consumers and healthcare professionals that provides total cholesterol test results in three minutes.
The Company's product aids the health-conscious consumer in monitoring their risk of heart disease. By regularly testing cholesterol at home, individuals can monitor the benefits of their diet, exercise and/or drug therapy programs. Monitoring these benefits can support the physician and the individual's efforts to improve compliance. Lifestream's products also integrate a smart card reader, further supporting compliance by storing test results on an individual's personal health card for future retrieval, trend analysis and assessment.
Lifestream's monitors are affordable, hand-held devices that provide users with accurate results in less than three minutes. The product line has been designed to accommodate The Data Concern(TM) Personal Health Card®, allowing multiple users the ability to store their personal results. Lifestream's products are now available in pharmacy and retail outlets nationwide. To find retailers that carry Lifestream's products, go to "Store Locator" on www.knowitforlife.com or contact Customer Care at 888-954-LIFE. For Company information, visit www.lifestreamtech.com.
This news release includes certain forward-looking statements within the meaning of the safe harbor protections of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, but are not limited to, statements regarding our current business plans, strategies and objectives that involve risks and uncertainties, and, in particular, statements referring to our expectations for increased market penetration and improved gross margins from our recently introduced second-generation consumer monitors and statements regarding our expectations that we can obtain necessary additional financing and investment. These forward-looking statements involve risks and uncertainties that could cause actual results to differ from anticipated results. The forward-looking statements are based on our current expectations and what we believe are reasonable assumptions given our knowledge of the relevant markets; however, our actual performance, results and achievements could differ materially from those expressed in, or implied by, these forward-looking statements. Factors, within and beyond our control, that could cause or contribute to such differences include, among others, the following: the success of our capital-raising and cost-cutting efforts, developing and marketing relatively new medical diagnostic devices, including technological advancements and innovations; consumer receptivity and preferences; availability, affordability and coverage terms of private and public medical insurance; political and regulatory environments and general economic and business conditions; the effects of our competition; the success of our operating, marketing and growth initiatives; development and operating costs; the amount and effectiveness of our advertising and promotional efforts; brand awareness; the existence of adverse publicity; changes in business strategies or development plans; quality and experience of our management; availability, terms and deployment of capital; labor and employee benefit costs; as well as those factors discussed in our most recent Registration Statement on Form SB-2 filed January 12, 2005, and in "Item 1 -- Business," "Item 6 -- Management's Discussion and Analysis or Plan of Operation," particularly the discussion under "Risk Factors -- Substantial Doubt regarding our Ability to Continue as a Going Concern" and elsewhere in our most recent Annual Report on Form 10-KSB for our fiscal year ended June 30, 2005, and the 10-QSB for the quarter ended December 31, 2005, all filed with the United States Securities and Exchange Commission. Readers are urged to carefully review and consider the various disclosures made by us in this report, in the aforementioned Form SB-2 and Forms 10-KSB and 10-QSB, and those detailed from time to time in our other reports and filings with the United States Securities and Exchange Commission that attempt to advise interested parties of the risks and factors that are likely to affect our business.
Contact:
Lifestream Technologies
Matt Colbert, 208-457-9409 ext. 1209
mattc@lifestreamtech.com
or
Investor Relations:
Equiti-trend LLC
Andy Arms, 800-585-6988
858-436-3350 local/international
LFTC@equititrend.com
Source: Lifestream Technologies, Inc.
Friday April 14, 6:30 am ET
Indicates That a Key Patent Will Be Granted
POST FALLS, Idaho--(BUSINESS WIRE)--April 14, 2006--Lifestream Technologies, Inc. (OTCBB:LFTC - News), a leading developer and marketer of consumer cholesterol monitors and professional screening instruments, has received a Notice of Allowance for a key patent from the U. S. Patent and Trademark office that further strengthens its Intellectual Property "IP" portfolio.
"Lifestream received a Notice of Allowance from the U. S. Patent and Trademark Office for its smartcard, secure medical data technology," stated patent counsel, Mike Mehrman. "This action indicates that the patent will be granted after the short period of time required to print the formal patent. This patent will cover Lifestream's Personal Health Card technology, including the unique method in which a person's medical data can be securely stored on a smartcard, as well as the secure storage of medical records on a backside server."
"With the subject of portable health records heating up, Lifestream sees this technology playing a key role in providing secure, portable medical records. The technology has already been licensed to one company, LifeNexus, Inc., and, as soon as the LifeNexus product enters the marketplace, Lifestream will be entitled to receive a royalty," said Matt Colbert, Lifestream's President and CFO.
"The Company's goal has been to secure its IP assets in such a way as to maximize their value to our shareholders through viable technologies. Our creative technical team continues to play a key role in our future success. As we move into the next generation of products, we will strive to be on the leading edge with the application of our technology in products of value to our customers and shareholders. Lifestream has a number of other applications related to our future product offerings," continued Mr. Colbert.
Ed Siemens has been appointed by the Board of Directors to the position of Chairman, and Matt Colbert has been appointed as President and Chief Financial Officer, replacing Christopher Maus, who will remain as a Director with the Company, as well as a consultant to facilitate financing and strategic business development.
About Lifestream Technologies, Inc.
The Company developed and currently markets a cholesterol monitor to consumers and healthcare professionals that provides total cholesterol test results in three minutes.
The Company's product aids the health-conscious consumer in monitoring their risk of heart disease. By regularly testing cholesterol at home, individuals can monitor the benefits of their diet, exercise and/or drug therapy programs. Monitoring these benefits can support the physician and the individual's efforts to improve compliance. Lifestream's products also integrate a smart card reader, further supporting compliance by storing test results on an individual's personal health card for future retrieval, trend analysis and assessment.
Lifestream's monitors are affordable, hand-held devices that provide users with accurate results in less than three minutes. The product line has been designed to accommodate The Data Concern(TM) Personal Health Card®, allowing multiple users the ability to store their personal results. Lifestream's products are now available in pharmacy and retail outlets nationwide. To find retailers that carry Lifestream's products, go to "Store Locator" on www.knowitforlife.com or contact Customer Care at 888-954-LIFE. For Company information, visit www.lifestreamtech.com.
This news release includes certain forward-looking statements within the meaning of the safe harbor protections of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, but are not limited to, statements regarding our current business plans, strategies and objectives that involve risks and uncertainties, and, in particular, statements referring to our expectations for increased market penetration and improved gross margins from our recently introduced second-generation consumer monitors and statements regarding our expectations that we can obtain necessary additional financing and investment. These forward-looking statements involve risks and uncertainties that could cause actual results to differ from anticipated results. The forward-looking statements are based on our current expectations and what we believe are reasonable assumptions given our knowledge of the relevant markets; however, our actual performance, results and achievements could differ materially from those expressed in, or implied by, these forward-looking statements. Factors, within and beyond our control, that could cause or contribute to such differences include, among others, the following: the success of our capital-raising and cost-cutting efforts, developing and marketing relatively new medical diagnostic devices, including technological advancements and innovations; consumer receptivity and preferences; availability, affordability and coverage terms of private and public medical insurance; political and regulatory environments and general economic and business conditions; the effects of our competition; the success of our operating, marketing and growth initiatives; development and operating costs; the amount and effectiveness of our advertising and promotional efforts; brand awareness; the existence of adverse publicity; changes in business strategies or development plans; quality and experience of our management; availability, terms and deployment of capital; labor and employee benefit costs; as well as those factors discussed in our most recent Registration Statement on Form SB-2 filed January 12, 2005, and in "Item 1 -- Business," "Item 6 -- Management's Discussion and Analysis or Plan of Operation," particularly the discussion under "Risk Factors -- Substantial Doubt regarding our Ability to Continue as a Going Concern" and elsewhere in our most recent Annual Report on Form 10-KSB for our fiscal year ended June 30, 2005, and the 10-QSB for the quarter ended December 31, 2005, all filed with the United States Securities and Exchange Commission. Readers are urged to carefully review and consider the various disclosures made by us in this report, in the aforementioned Form SB-2 and Forms 10-KSB and 10-QSB, and those detailed from time to time in our other reports and filings with the United States Securities and Exchange Commission that attempt to advise interested parties of the risks and factors that are likely to affect our business.
Contact:
Lifestream Technologies
Matt Colbert, 208-457-9409 ext. 1209
mattc@lifestreamtech.com
or
Investor Relations:
Equiti-trend LLC
Andy Arms, 800-585-6988
858-436-3350 local/international
LFTC@equititrend.com
Source: Lifestream Technologies, Inc.
LFTC wird wieder interessant...
kann nur hoch gehen
kann nur hoch gehen
dein wort in gottes ohr........aber wie kommst du darauf?
Hammergeile Meldung.
Da könnte es ziemlich abgehen!!!
Da könnte es ziemlich abgehen!!!
hmmm......war wohl doch nix mit der hammermeldung
Antwort auf Beitrag Nr.: 21.221.426 von OTTO29 am 18.04.06 11:46:40abwarten, LFTC hat immer versetzt reagiert...
das wichtigste ist momentan eh die finanzierung!
wenn da mal news kommen, worauf ich setze, dann haben wir hier einen vervielfacher...
haus und hof sollte man allerdings nicht setzen
das wichtigste ist momentan eh die finanzierung!
wenn da mal news kommen, worauf ich setze, dann haben wir hier einen vervielfacher...
haus und hof sollte man allerdings nicht setzen
mal doch mal ein günstiges szenarium........ich hab da nämlich haus und hof drauf gesetzt ..........wieviel häuser und höfe hab ich denn dann......wenn der zock gut gehen sollte ?
..........wieviel häuser und höfe hab ich denn dann......wenn der zock gut gehen sollte ?
ich weiss ja nicht wieviel ha du gesetzt hast.. aber wenns gut geht kannste dir bestimmt ordentlich was dazukaufen
noch ein paar zocks die reinlaufen......dann würd ich mir gerne schönes land kaufen.......ein paar pferde draufstellen und sie mir den ganzen tag ansehen.....diese ganze jagd nach dem geld ist eh das falsche leben 
nö macht auch keinen spaß mehr....ist nur noch mittel zum zweck....und hätte ich vor 1000 tagen solarworld gekauft wäre ich schon wech hier
Lifestream Technologies Sells Asset for $4.5 Million
Tuesday May 16, 6:30 am ET
Company Reduces Debt by $4.5 Million Through the Transaction
POST FALLS, Idaho--(BUSINESS WIRE)--May 16, 2006--Lifestream Technologies, Inc. (OTCBB:LFTC - News), a leading supplier of cholesterol monitors, announced today that it has entered into a patent and trademark assignment and license assumption agreement with RAB Special Situations (Master) Fund Limited ("RAB") for the sale of certain patents pending, licenses, and other intellectual property for the Company's personal health card technology.
"We are pleased we were able to structure this deal to bring such value to our shareholders," said Matt Colbert, Lifestream's CFO. "Since January 2005, we have converted into common stock approximately $2.35 million in debt and accrued interest and significantly reduced general and administrative expenses. Coupled with this debt reduction, we are better positioned for a capital investment to facilitate the expected roll-out of our new Lifestream Two in One Blood Pressure/Cholesterol Monitor. We will continue to pursue additional cost-saving measures, as well as debt reduction and debt restructuring over the coming months."
In connection with this agreement, the Company assigned to RAB all of its right, title and interest in certain patent applications, trademarks and related license agreements in exchange for the cancellation of $4.5 million of secured and unsecured debt. The cancelled debt consisted of (a) $3,480,000 evidenced by various convertible term notes previously issued by the Company in favor of RAB and (b) $1,020,000 evidenced by a loan agreement dated November 12, 2004 between the Company and RAB under which the outstanding balance as of the date of the assignment was $2,869,740.
About Lifestream Technologies
The Company developed and currently markets a cholesterol monitor to consumers and healthcare professionals that provides test results in three minutes.
The Company's product line aids the health conscious consumer in monitoring their risk of heart disease. By regularly testing cholesterol at home, individuals can monitor the benefits of their diet, exercise and/or drug therapy programs. Monitoring these benefits can support the physician and the individual's efforts to improve compliance. Lifestream's products also integrate a smart card reader further supporting compliance by storing test results on an individual's personal health card for future retrieval, trend analysis and assessment.
Lifestream's monitor is an affordable, hand-held device that provides users with accurate results in less than three minutes. The product line has been designed to accommodate The Data Concern(TM) Personal Health Card® allowing multiple users the ability to store their personal results. Lifestream's products are now available in pharmacy and retail outlets nationwide. To find retailers that carry Lifestream's products, go to "Store Locator" on www.knowitforlife.com or contact Customer Care at 888-954-LIFE. For Company information, visit www.lifestreamtech.com.
This news release includes certain forward-looking statements within the meaning of the safe harbor protections of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, but are not limited to, statements regarding our current business plans, strategies and objectives that involve risks and uncertainties, and in particular statements referring to our expectations for increased market penetration and improved gross margins from our recently introduced second generation consumer monitors and statements regarding our expectations that we can obtain necessary additional financing and investment. These forward-looking statements involve risks and uncertainties that could cause actual results to differ from anticipated results. The forward-looking statements are based on our current expectations and what we believe are reasonable assumptions given our knowledge of the relevant markets; however, our actual performance, results and achievements could differ materially from those expressed in, or implied by, these forward-looking statements. Factors, within and beyond our control, that could cause or contribute to such differences include, among others, the following: the success of our capital-raising and cost-cutting efforts, developing and marketing relatively new medical diagnostic devices, including technological advancements and innovations; consumer receptivity and preferences; availability, affordability and coverage terms of private and public medical insurance; political and regulatory environments and general economic and business conditions; the effects of our competition; the success of our operating, marketing and growth initiatives; development and operating costs; the amount and effectiveness of our advertising and promotional efforts; brand awareness; the existence of adverse publicity; changes in business strategies or development plans; quality and experience of our management; availability, terms and deployment of capital; labor and employee benefit costs; as well as those factors discussed in our most recent Registration Statement on Form SB-2 filed January 12, 2005, and in "Item 1 - Business," "Item 6 - Management's Discussion and Analysis or Plan of Operation," particularly the discussion under "Risk Factors - Substantial Doubt regarding our Ability to Continue as a Going Concern" and elsewhere in our most recent Annual Report on Form 10-KSB for our fiscal year ended June 30, 2005, and the 10-QSB for the quarter ended March 31, 2006, all filed with the United States Securities and Exchange Commission. Readers are urged to carefully review and consider the various disclosures made by us in this report, in the aforementioned Form SB-2 and Forms 10-KSB and 10-QSB, and those detailed from time to time in our other reports and filings with the United States Securities and Exchange Commission that attempt to advise interested parties of the risks and factors that are likely to affect our business.
Contact:
Lifestream Technologies
Matt Colbert, 208-457-9409 ext. 1209
mattc@lifestreamtech.com
Source: Lifestream Technologies
Tuesday May 16, 6:30 am ET
Company Reduces Debt by $4.5 Million Through the Transaction
POST FALLS, Idaho--(BUSINESS WIRE)--May 16, 2006--Lifestream Technologies, Inc. (OTCBB:LFTC - News), a leading supplier of cholesterol monitors, announced today that it has entered into a patent and trademark assignment and license assumption agreement with RAB Special Situations (Master) Fund Limited ("RAB") for the sale of certain patents pending, licenses, and other intellectual property for the Company's personal health card technology.
"We are pleased we were able to structure this deal to bring such value to our shareholders," said Matt Colbert, Lifestream's CFO. "Since January 2005, we have converted into common stock approximately $2.35 million in debt and accrued interest and significantly reduced general and administrative expenses. Coupled with this debt reduction, we are better positioned for a capital investment to facilitate the expected roll-out of our new Lifestream Two in One Blood Pressure/Cholesterol Monitor. We will continue to pursue additional cost-saving measures, as well as debt reduction and debt restructuring over the coming months."
In connection with this agreement, the Company assigned to RAB all of its right, title and interest in certain patent applications, trademarks and related license agreements in exchange for the cancellation of $4.5 million of secured and unsecured debt. The cancelled debt consisted of (a) $3,480,000 evidenced by various convertible term notes previously issued by the Company in favor of RAB and (b) $1,020,000 evidenced by a loan agreement dated November 12, 2004 between the Company and RAB under which the outstanding balance as of the date of the assignment was $2,869,740.
About Lifestream Technologies
The Company developed and currently markets a cholesterol monitor to consumers and healthcare professionals that provides test results in three minutes.
The Company's product line aids the health conscious consumer in monitoring their risk of heart disease. By regularly testing cholesterol at home, individuals can monitor the benefits of their diet, exercise and/or drug therapy programs. Monitoring these benefits can support the physician and the individual's efforts to improve compliance. Lifestream's products also integrate a smart card reader further supporting compliance by storing test results on an individual's personal health card for future retrieval, trend analysis and assessment.
Lifestream's monitor is an affordable, hand-held device that provides users with accurate results in less than three minutes. The product line has been designed to accommodate The Data Concern(TM) Personal Health Card® allowing multiple users the ability to store their personal results. Lifestream's products are now available in pharmacy and retail outlets nationwide. To find retailers that carry Lifestream's products, go to "Store Locator" on www.knowitforlife.com or contact Customer Care at 888-954-LIFE. For Company information, visit www.lifestreamtech.com.
This news release includes certain forward-looking statements within the meaning of the safe harbor protections of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, but are not limited to, statements regarding our current business plans, strategies and objectives that involve risks and uncertainties, and in particular statements referring to our expectations for increased market penetration and improved gross margins from our recently introduced second generation consumer monitors and statements regarding our expectations that we can obtain necessary additional financing and investment. These forward-looking statements involve risks and uncertainties that could cause actual results to differ from anticipated results. The forward-looking statements are based on our current expectations and what we believe are reasonable assumptions given our knowledge of the relevant markets; however, our actual performance, results and achievements could differ materially from those expressed in, or implied by, these forward-looking statements. Factors, within and beyond our control, that could cause or contribute to such differences include, among others, the following: the success of our capital-raising and cost-cutting efforts, developing and marketing relatively new medical diagnostic devices, including technological advancements and innovations; consumer receptivity and preferences; availability, affordability and coverage terms of private and public medical insurance; political and regulatory environments and general economic and business conditions; the effects of our competition; the success of our operating, marketing and growth initiatives; development and operating costs; the amount and effectiveness of our advertising and promotional efforts; brand awareness; the existence of adverse publicity; changes in business strategies or development plans; quality and experience of our management; availability, terms and deployment of capital; labor and employee benefit costs; as well as those factors discussed in our most recent Registration Statement on Form SB-2 filed January 12, 2005, and in "Item 1 - Business," "Item 6 - Management's Discussion and Analysis or Plan of Operation," particularly the discussion under "Risk Factors - Substantial Doubt regarding our Ability to Continue as a Going Concern" and elsewhere in our most recent Annual Report on Form 10-KSB for our fiscal year ended June 30, 2005, and the 10-QSB for the quarter ended March 31, 2006, all filed with the United States Securities and Exchange Commission. Readers are urged to carefully review and consider the various disclosures made by us in this report, in the aforementioned Form SB-2 and Forms 10-KSB and 10-QSB, and those detailed from time to time in our other reports and filings with the United States Securities and Exchange Commission that attempt to advise interested parties of the risks and factors that are likely to affect our business.
Contact:
Lifestream Technologies
Matt Colbert, 208-457-9409 ext. 1209
mattc@lifestreamtech.com
Source: Lifestream Technologies
Antwort auf Beitrag Nr.: 21.605.027 von aloevera2750 am 16.05.06 14:32:16LIFESTREAM TECHNOLOGIEN Schneller Anführungsstrich: LFTC
Lifestream Technologie-Verkäufe Wert für $4.5 Million; Firma verringert Schuld um $4.5 Million durch die Verhandlung
5/16/2006
PFOSTEN-FÄLLE, Idaho, 16. Mai 2006 (GESCHÄFT LEITUNG) --
Lifestream Technologies, Inc. (OTCBB: LFTC), ein führender Lieferant der Cholesterinmonitoren, heute verkündet, daß es an einer Patent- und Warenzeichenanweisung und am Lizenzübernahmevertrag mit begrenzten RAB der speziellen Situationen (Vorlagen) Kapital („RAB“) für den Verkauf bestimmter schwebender Patente teilgenommen hat, Lizenzen und anderes geistiges Eigentum für die persönliche Technologie Karte Gesundheit der Firma.
„Wir sind wir in der Lage waren, dieses Abkommen zu strukturieren, um solchen Wert auf unsere Aktionäre anwachsen zu lassen,“ erfreut, sagte mattes Colbert, CFO Lifestreams. „Seit Januar 2005, haben wir in Stammaktien ungefähr $2.35 Million in der Schuld und in anfallendem Interesse umgewandelt und erheblich die allgemeinen und Verwaltungskosten verringert. Verbunden worden mit dieser Schuldenreduzierung, werden wir besser in Position gebracht, damit eine Investition erwartet rollen-heraus von unserem neuen Lifestream zwei in einem Blutdruck-/Cholesterin-Monitor erleichtert. Wir fahren fort, zusätzliche kostensparende Masse, sowie Schuldenreduzierung und Umschuldung überschuß auszuüben die kommenden Monate.“
In Zusammenhang mit dieser Vereinbarung wies die Firma RAB alle seines Rechtes, Titels und Interesses an bestimmten Patentanfragen, eingetragene Warenzeichen zu und bezog Lizenzvereinbarungen gegen die Annullierung von $4.5 Million der gesicherten und ungesicherten Schuld. Die annullierte Schuld bestand aus (a) $3.480.000 bewiesen durch die verschiedenen umwandelbaren Bezeichnung Anmerkungen, die vorher durch die Firma zugunsten RAB herausgegeben wurden und (b) $1.020.000 bewiesen durch einen Kreditvertrag, der zwischen der Firma und dem RAB, unter denen die hervorragende Balance ab dem Datum der Anweisung, vom 12. November 2004 ist $2.869.740 war.
Über Lifestream Technologien
Die entwickelte Firma und vermarktet z.Z. einen Cholesterinmonitor zu den Verbrauchern und zu den healthcare Fachleuten, der Testergebnisse in drei Minuten liefert.
Die Produktserie der Firma hilft dem Gesundheit bewußten Verbraucher, wenn sie ihre Gefahr der Herzkrankheit überwacht. Indem sie regelmäßig zu Hause Cholesterin prüfen, können Einzelpersonen den Nutzen ihrer Diät, übung und/oder Drogetherapieprogramme überwachen. Die überwachung dieses Nutzens kann den Arzt und die Bemühungen der Einzelperson stützen, Befolgung zu verbessern. Produkte Lifestreams integrieren auch einen intelligenten Kartenleser, der weiter Befolgung stützt, indem sie Testergebnisse auf persönlicher Karte die Gesundheit einer Einzelperson für zukünftige Wiederherstellung, Trendanalyse und Einschätzung speichern.
Monitor Lifestreams ist eine erschwingliche, Handvorrichtung, die Benutzer mit genauen Resultaten in weniger als drei Minuten versieht. Die Produktserie ist entworfen worden, um die Daten-Interesse (TM) persönliche Gesundheit Karte (R) unterzubringen mehreren Benutzern die Fähigkeit zugestehend, ihre persönlichen Resultate zu speichern. Produkte Lifestreams sind jetzt in der Apotheke und in den Einzelhandelsgeschäften im ganzen Land vorhanden. Um Einzelhändler zu finden die Produkte Lifestreams tragen, gehen „Verzeichnis“ auf www.knowitforlife.com zu speichern oder mit Kunde Obacht an 888-954-LIFE in Verbindung zu treten. Zu Firmainformation www.lifestreamtech.com besuchen.
Lifestream Technologie-Verkäufe Wert für $4.5 Million; Firma verringert Schuld um $4.5 Million durch die Verhandlung
5/16/2006
PFOSTEN-FÄLLE, Idaho, 16. Mai 2006 (GESCHÄFT LEITUNG) --
Lifestream Technologies, Inc. (OTCBB: LFTC), ein führender Lieferant der Cholesterinmonitoren, heute verkündet, daß es an einer Patent- und Warenzeichenanweisung und am Lizenzübernahmevertrag mit begrenzten RAB der speziellen Situationen (Vorlagen) Kapital („RAB“) für den Verkauf bestimmter schwebender Patente teilgenommen hat, Lizenzen und anderes geistiges Eigentum für die persönliche Technologie Karte Gesundheit der Firma.
„Wir sind wir in der Lage waren, dieses Abkommen zu strukturieren, um solchen Wert auf unsere Aktionäre anwachsen zu lassen,“ erfreut, sagte mattes Colbert, CFO Lifestreams. „Seit Januar 2005, haben wir in Stammaktien ungefähr $2.35 Million in der Schuld und in anfallendem Interesse umgewandelt und erheblich die allgemeinen und Verwaltungskosten verringert. Verbunden worden mit dieser Schuldenreduzierung, werden wir besser in Position gebracht, damit eine Investition erwartet rollen-heraus von unserem neuen Lifestream zwei in einem Blutdruck-/Cholesterin-Monitor erleichtert. Wir fahren fort, zusätzliche kostensparende Masse, sowie Schuldenreduzierung und Umschuldung überschuß auszuüben die kommenden Monate.“
In Zusammenhang mit dieser Vereinbarung wies die Firma RAB alle seines Rechtes, Titels und Interesses an bestimmten Patentanfragen, eingetragene Warenzeichen zu und bezog Lizenzvereinbarungen gegen die Annullierung von $4.5 Million der gesicherten und ungesicherten Schuld. Die annullierte Schuld bestand aus (a) $3.480.000 bewiesen durch die verschiedenen umwandelbaren Bezeichnung Anmerkungen, die vorher durch die Firma zugunsten RAB herausgegeben wurden und (b) $1.020.000 bewiesen durch einen Kreditvertrag, der zwischen der Firma und dem RAB, unter denen die hervorragende Balance ab dem Datum der Anweisung, vom 12. November 2004 ist $2.869.740 war.
Über Lifestream Technologien
Die entwickelte Firma und vermarktet z.Z. einen Cholesterinmonitor zu den Verbrauchern und zu den healthcare Fachleuten, der Testergebnisse in drei Minuten liefert.
Die Produktserie der Firma hilft dem Gesundheit bewußten Verbraucher, wenn sie ihre Gefahr der Herzkrankheit überwacht. Indem sie regelmäßig zu Hause Cholesterin prüfen, können Einzelpersonen den Nutzen ihrer Diät, übung und/oder Drogetherapieprogramme überwachen. Die überwachung dieses Nutzens kann den Arzt und die Bemühungen der Einzelperson stützen, Befolgung zu verbessern. Produkte Lifestreams integrieren auch einen intelligenten Kartenleser, der weiter Befolgung stützt, indem sie Testergebnisse auf persönlicher Karte die Gesundheit einer Einzelperson für zukünftige Wiederherstellung, Trendanalyse und Einschätzung speichern.
Monitor Lifestreams ist eine erschwingliche, Handvorrichtung, die Benutzer mit genauen Resultaten in weniger als drei Minuten versieht. Die Produktserie ist entworfen worden, um die Daten-Interesse (TM) persönliche Gesundheit Karte (R) unterzubringen mehreren Benutzern die Fähigkeit zugestehend, ihre persönlichen Resultate zu speichern. Produkte Lifestreams sind jetzt in der Apotheke und in den Einzelhandelsgeschäften im ganzen Land vorhanden. Um Einzelhändler zu finden die Produkte Lifestreams tragen, gehen „Verzeichnis“ auf www.knowitforlife.com zu speichern oder mit Kunde Obacht an 888-954-LIFE in Verbindung zu treten. Zu Firmainformation www.lifestreamtech.com besuchen.
Antwort auf Beitrag Nr.: 21.605.063 von Saftladen am 16.05.06 14:34:30Tolle Übersetzung!
Danke fürs News einstellen.
Ich bin dran es zu übersetzen, aber Schulden verringern um 4,5 Mio. $ stimmt schonmal.
Danke fürs News einstellen.
Ich bin dran es zu übersetzen, aber Schulden verringern um 4,5 Mio. $ stimmt schonmal.
ich war es nicht
das ist google - deutsch
das ist google - deutsch
Antwort auf Beitrag Nr.: 21.605.259 von Saftladen am 16.05.06 14:45:04Ja, weiss schon, war keine Kritik, aber das is immer ne ganz schöne Schei*** diese Übersetzungen.
Liest sich für mich so, als hatten sie massiv Schulden bei Master Fund die sie nicht begleichen konnten.
Jetzt haben sie Ihnen die Rechte an Patenten und Lizenzen für die Lifestream Gesundheitskarte.
Dadurch haben sich die Gesamtschulden um 4,5 Mio. $ gesenkt.
Diesen Deal haben sie abgeschlossen um allgemein besser aufgestellt zu sein, da sie den Lifestream 2in1 Blut und Cholesterin Monitor US-weit vertreiben wollen. Das soll in Kürze so weit sein.
Liest sich für mich so, als hatten sie massiv Schulden bei Master Fund die sie nicht begleichen konnten.
Jetzt haben sie Ihnen die Rechte an Patenten und Lizenzen für die Lifestream Gesundheitskarte.
Dadurch haben sich die Gesamtschulden um 4,5 Mio. $ gesenkt.
Diesen Deal haben sie abgeschlossen um allgemein besser aufgestellt zu sein, da sie den Lifestream 2in1 Blut und Cholesterin Monitor US-weit vertreiben wollen. Das soll in Kürze so weit sein.
Antwort auf Beitrag Nr.: 21.605.063 von Saftladen am 16.05.06 14:34:30danke dir
aber drüben passiert ja gar nicht
aber drüben passiert ja gar nicht
das ist normal
meistens fallen die sogar
die amis brauchen immer ein paar tage
meistens fallen die sogar
die amis brauchen immer ein paar tage
Antwort auf Beitrag Nr.: 21.607.361 von Saftladen am 16.05.06 16:25:11danke dir dann heisst es wieder warten auf denn frühling
dann heisst es wieder warten auf denn frühling
Mal ne Frage, hat jemand die Aktien in Frankfurt schon mal verkauft bekommen?
kann jemand damit was anfangen mein englisch ist schlecht
danke
Stocks >> NEWS
Lifestream enters into agreement with company [The Idaho Statesman, Boise]
May 23--Lifestream Technologies Inc., a leading supplier of cholesterol monitors, has entered into a patent and trademark assignment and license assumption agreement with RAP Special Situations (Master) Fund Limited for the sale of certain patents pending, licenses, and other intellectual property for the company's personal-health-card technology.
"We are pleased we were able to structure this deal to bring such value to our shareholders," said Matt Colbert, Lifestream's chief financial officer.
"Since January 2005, we have converted into common stock approximately $2.35 million in debt and accrued interest and significantly reduced general and administrative expenses.
"Coupled with this debt reduction, we are better positioned for a capital investment to facilitate the expected roll-out of our new Lifestream Two in One Blood Pressure/Cholesterol Monitor.
"We will continue to pursue additional cost-saving measures, as well as debt reduction and debt restructuring over the coming months."
In connection with this agreement, the company assigned to RAB all if its right, title and interest in certain patent applications, trademarks and related license agreements in exchange for the cancellation of $4.5 million of secured and unsecured debt.
Copyright (c) 2006, The Idaho Statesman, Boise
Distributed by Knight Ridder/Tribune Business News. For information on republishing this content, contact us at (800) 661-2511 (U.S.), (213) 237-4914 (worldwide), fax (213) 237-6515, or e-mail reprints@krtinfo.com.
danke
Stocks >> NEWS
Lifestream enters into agreement with company [The Idaho Statesman, Boise]
May 23--Lifestream Technologies Inc., a leading supplier of cholesterol monitors, has entered into a patent and trademark assignment and license assumption agreement with RAP Special Situations (Master) Fund Limited for the sale of certain patents pending, licenses, and other intellectual property for the company's personal-health-card technology.
"We are pleased we were able to structure this deal to bring such value to our shareholders," said Matt Colbert, Lifestream's chief financial officer.
"Since January 2005, we have converted into common stock approximately $2.35 million in debt and accrued interest and significantly reduced general and administrative expenses.
"Coupled with this debt reduction, we are better positioned for a capital investment to facilitate the expected roll-out of our new Lifestream Two in One Blood Pressure/Cholesterol Monitor.
"We will continue to pursue additional cost-saving measures, as well as debt reduction and debt restructuring over the coming months."
In connection with this agreement, the company assigned to RAB all if its right, title and interest in certain patent applications, trademarks and related license agreements in exchange for the cancellation of $4.5 million of secured and unsecured debt.
Copyright (c) 2006, The Idaho Statesman, Boise
Distributed by Knight Ridder/Tribune Business News. For information on republishing this content, contact us at (800) 661-2511 (U.S.), (213) 237-4914 (worldwide), fax (213) 237-6515, or e-mail reprints@krtinfo.com.
Antwort auf Beitrag Nr.: 21.765.808 von aloevera2750 am 23.05.06 22:12:10Mai 23 -- Lifestream Technologies Inc., ein führender Lieferant des Cholesterins überwacht, hat an einer Patent- und Warenzeichenanweisung und am Lizenzübernahmevertrag mit RAP der speziellen Situationen (Vorlagen) Kapital teilgenommen, die für den Verkauf bestimmter schwebender Patente, der Lizenzen und anderen geistigen Eigentums für die Technologie Persönlich-Gesundheitkarte der company\s begrenzt wird. "wir sind wir in der LageWAREN, dieses Abkommen zu strukturieren, um solchen Wert auf unsere Aktionäre anwachsen zu lassen," erfreut, sagte mattes Colbert, Lifestream\s Finanzleiter. "seit Januar 2005, haben wir in Stammaktien ungefähr $2.35 Million in der Schuld und in anfallendem Interesse umgewandelt und erheblich die allgemeinen und Verwaltungskosten verringert.ALTAVISTA DEUTSCH
ALTAVISTA DEUTSCH
Kam das nachbörslich?????Klarer KAuf!!!!
Meiner Meinung nach ist das nur noch mal die letzte News über Assets Sale umgeschrieben.
Nichts neues!
Nichts neues!
Antwort auf Beitrag Nr.: 21.771.897 von boersen_loder am 24.05.06 09:43:15ist hier nichts mehr los soll ich meine aktien wegschmeißen oder wohnung tapezieren
Antwort auf Beitrag Nr.: 21.771.897 von boersen_loder am 24.05.06 09:43:15ist hier nichts mehr los soll ich meine aktien wegschmeißen oder wohnung tapezieren
Was ist los mit lifestream??
Antwort auf Beitrag Nr.: 25.416.196 von Dog81 am 15.11.06 17:13:36Lifestream Technologies, Inc. Files for Chapter 11 Protection, Takes Action to Sell Its Assets
Business Wire - November 30, 2006 17:52
POST FALLS, Idaho, Nov 30, 2006 (BUSINESS WIRE) -- Lifestream Technologies, Inc. (OTCBB:LFTC) announced that yesterday it has filed a petition for protection under Chapter 11 of the United States Bankruptcy Code in the Untied States Bankruptcy Court for the District of Nevada. Case No. 06-13589. As a "debtor in possession," the Company remains in possession of its assets and properties, and continues to operate its business pursuant to Sections 1107(a) and 1108 of the Bankruptcy Code.
In connection with the bankruptcy filing referred to above, on November 27, 2006, the Company entered into an asset purchase agreement with Polymer Technology Systems, Inc. to sell substantially all of the Company's assets for $750,000, subject to higher and better offers. To consummate the sale, the Company filed a motion pursuant to Section 363(f) of the Bankruptcy Code to seek Bankruptcy Court approval for sale of the assets referred to above. As its bankruptcy pleadings detail, based on preliminary indications, the Company believes that after the sale it is unlikely that any assets will remain for distribution to the common shareholders.
Certain additional information concerning the matters announced in this release are contained in a current report on Form 8-K to be filed with the Securities and Exchange Commission by the Company.
Business Wire - November 30, 2006 17:52
POST FALLS, Idaho, Nov 30, 2006 (BUSINESS WIRE) -- Lifestream Technologies, Inc. (OTCBB:LFTC) announced that yesterday it has filed a petition for protection under Chapter 11 of the United States Bankruptcy Code in the Untied States Bankruptcy Court for the District of Nevada. Case No. 06-13589. As a "debtor in possession," the Company remains in possession of its assets and properties, and continues to operate its business pursuant to Sections 1107(a) and 1108 of the Bankruptcy Code.
In connection with the bankruptcy filing referred to above, on November 27, 2006, the Company entered into an asset purchase agreement with Polymer Technology Systems, Inc. to sell substantially all of the Company's assets for $750,000, subject to higher and better offers. To consummate the sale, the Company filed a motion pursuant to Section 363(f) of the Bankruptcy Code to seek Bankruptcy Court approval for sale of the assets referred to above. As its bankruptcy pleadings detail, based on preliminary indications, the Company believes that after the sale it is unlikely that any assets will remain for distribution to the common shareholders.
Certain additional information concerning the matters announced in this release are contained in a current report on Form 8-K to be filed with the Securities and Exchange Commission by the Company.
DurchsuchenBeitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
| Wertpapier | Beiträge | |
|---|---|---|
| 70 | ||
| 55 | ||
| 52 | ||
| 41 | ||
| 40 | ||
| 29 | ||
| 16 | ||
| 15 | ||
| 13 | ||
| 12 |
| Wertpapier | Beiträge | |
|---|---|---|
| 9 | ||
| 9 | ||
| 8 | ||
| 7 | ||
| 7 | ||
| 7 | ||
| 7 | ||
| 6 | ||
| 6 | ||
| 5 |
